Roberto Simone is a Principal Scientist at NeoVac Ltd, specializing in mRNA biology and therapeutics since 2023. Previously, Roberto served as a Research Associate Postdoc Fellow at University College London from 2010 to 2022, focusing on the co-transcriptional and translational regulation of the human Tau gene and engaging in research related to gene therapy for Alzheimer's disease and other tauopathies. Roberto earned a PhD in Structural and Functional Genomics from the ISAS International School for Advanced Studies in Trieste, Italy, and holds an MSc in Biological Sciences with honors from the University La Sapienza of Rome.
This person is not in the org chart
This person is not in any teams
This person is not in any offices